SEC Filings - Aerovate Therapeutics, Inc.

Filing date	Form	Description	View
June 29, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-087010.pdf 0001104659-21-087010.rtf 0001104659-21-087010.xls View HTML
June 29, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-087013.pdf 0001104659-21-087013.rtf 0001104659-21-087013.xls View HTML
June 29, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-087033.pdf 0001104659-21-087033.rtf 0001104659-21-087033.xls View HTML
June 29, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-087034.pdf 0001104659-21-087034.rtf 0001104659-21-087034.xls View HTML
June 29, 2021	EFFECT	EFFECT	9999999995-21-002582.pdf 9999999995-21-002582.rtf 9999999995-21-002582.xls View HTML
June 25, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001104659-21-085693.pdf 0001104659-21-085693.rtf 0001104659-21-085693.xls View HTML
June 25, 2021	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	0001104659-21-085707.pdf 0001104659-21-085707.rtf 0001104659-21-085707.xls View HTML
June 25, 2021	CORRESP	CORRESP	0001104659-21-085700.pdf 0001104659-21-085700.rtf 0001104659-21-085700.xls View HTML
June 25, 2021	CORRESP	CORRESP	0001104659-21-085705.pdf 0001104659-21-085705.rtf 0001104659-21-085705.xls View HTML
June 24, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001104659-21-084790.pdf 0001104659-21-084790.rtf 0001104659-21-084790.xls View HTML

Data provided by Kaleidoscope.